Gastric cancer is one of the most commonly delayed diagnoses in primary care. The symptoms — indigestion, early satiety, mild epigastric discomfort — look like GERD. They often get treated like GERD. In the United States, the average patient waits more than 229 days for the right answer. Five-year survival is 75% at Stage I and 5% at Stage IV. With 31,510 new cases and 10,740 deaths projected in 2026, and more than 80% of patients aged 55 or older, this is a condition where primary care recognition changes everything.
AAVBC's Gastric Cancer Quick Reference Guide is a clinical and documentation reference for a cancer that rewards vigilance. It covers the early signs most likely to be attributed to something else, H. pylori documentation, ICD-10 subsite coding, biomarker-guided treatment, metastatic site coding, and MEAT documentation standards.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of gastric cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Gastric cancer is one of the most commonly delayed diagnoses in primary care. The symptoms — indigestion, early satiety, mild epigastric discomfort — look like GERD. They often get treated like GERD. In the United States, the average patient waits more than 229 days for the right answer. Five-year survival is 75% at Stage I and 5% at Stage IV. With 31,510 new cases and 10,740 deaths projected in 2026, and more than 80% of patients aged 55 or older, this is a condition where primary care recognition changes everything.
AAVBC's Gastric Cancer Quick Reference Guide is a clinical and documentation reference for a cancer that rewards vigilance. It covers the early signs most likely to be attributed to something else, H. pylori documentation, ICD-10 subsite coding, biomarker-guided treatment, metastatic site coding, and MEAT documentation standards.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of gastric cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
